In addition, confer to the Taxol-treated ovarian cancer patients, elevated AQP4, AQP5, AQP8, and AQP10 mRNA expression illustrated no correlation, whereas increased expression of AQP0 and AQP1 revealed poor OS and increased expression of AQP3, AQP6, and AQP11 showed improved OS in ovarian cancer patients. This evidence concerns the gene AQP1 and ovarian cancer.